Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma

Authors

Kai Huang (ORCID: https://orcid.org/0000-0002-3991-5107)

Institutions

California University of Pennsylvania (US)
Qilu Hospital of Shandong University (CN)
University of Pennsylvania (US)

Publication Details

Journal: Cancer Communications
Published: 2024-11-13
DOI: https://doi.org/10.1002/cac2.12628
Primary Topic: Psoriasis: Treatment and Pathogenesis
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma

Kai Huang

Nov 13, 2024

Cancer Communications

Psoriasis: Treatment and Pathogenesis

article

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma

Kai Huang

November 13, 2024article en

Abstract

No abstract available for this paper.

Cancer CommunicationsVol. 45(1)

California University of Pennsylvania (US), Qilu Hospital of Shandong University (CN), University of Pennsylvania (US)

National Natural Science Foundation of China

Zero hunger

Openalex Percentile: Top 73%

Psoriasis: Treatment and Pathogenesis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma — Kai Huang · Cancer Communications (2024) | TGRS Research Map | TGRS